C16 Biosciences

C16 Biosciences

C16 Biosciences is a biotechnology company making alternatives to palm oil founded in 2017 by Shara Ticku.

C16 Biosciences is a biotechnology company making alternatives to palm oil that is headquartered in Somerville, Massachusetts and was founded in 2017 by David Heller, Harry McNamara, and Shara Ticku.

C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, their stated aim is to reduce the environmental footprint of palm oil production and protect natural land, wildlife and resources in the process.They have developed technology to brew an alternative to palm oil from microbes.They are brewing palm oil using fermentation.

Funding

Seed

On August 20, 2018 C16 Biosciences announced raising $4 million in seed funding from Y Combinator, Wei Guo, UpHonest Capital, and Soma Capital.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
C16 Biosciences, Inc. funding round, March 2020
19,999,994
March 2020
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

David Heller

Employee

Harry McNamara

Employee

Jason Gray

Investor

Shara Ticku

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.